Skip to Content

Uridine Pregnancy and Breastfeeding Warnings

Uridine is also known as: Vistogard, Xuriden

Uridine Pregnancy Warnings

Safety has not been established during pregnancy.

US FDA pregnancy category: Not Assigned

Comments: Limited case reports of use during human pregnancy are insufficient to inform a drug-associated risk of birth defects and miscarriage.

Animal studies have not revealed any evidence of teratogenicity or fetal harm, and there was no effect on maternal body weight, overall health, fertility, or general reproductive performance.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Uridine Breastfeeding Warnings

Safety has not been established during lactation; Benefit should outweigh risk.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant and on milk production are unknown.

See references

References for pregnancy information

  1. "Product Information. Xuriden (uridine)." Wellstat Therapeutics Corp, Gaithersburg, MD.
  2. "Product Information. Vistogard (uridine)." BTG International Inc, West Conshohocken, PA.

References for breastfeeding information

  1. "Product Information. Xuriden (uridine)." Wellstat Therapeutics Corp, Gaithersburg, MD.
  2. "Product Information. Vistogard (uridine)." BTG International Inc, West Conshohocken, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide